The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cellular Health Assays Market Research Report 2025
Synopsis
Cell Health Assays are designed to measure various parameters leading to cell viability, cell death (apoptosis or necrosis), cytotoxicity and cell proliferation.
The global Cellular Health Assays market was valued at US$ 2622.1 million in 2023 and is anticipated to reach US$ 4435.9 million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.
The Cellular Health Assays market is a pivotal and rapidly advancing segment within the life sciences and pharmaceutical industry, providing critical tools for assessing the viability, function, and integrity of cells. Cellular health assays encompass a diverse range of techniques, including cell proliferation assays, cell viability assays, and cytotoxicity assays, which are instrumental in drug development, disease research, and toxicology testing. These assays are highly valued for their ability to offer insights into cellular responses, mechanisms, and drug effects, enabling researchers to make informed decisions in areas like drug discovery, cancer research, and regenerative medicine. The market is characterized by ongoing technological advancements, such as high-throughput screening methods, 3D cell culture systems, and automation, which enhance the efficiency and accuracy of cellular health assessments. Leading providers in the life sciences and biotechnology sector, including Thermo Fisher Scientific, Promega Corporation, and PerkinElmer, focus on delivering advanced assay technologies that cater to the diverse demands of researchers and pharmaceutical companies. As the need for in-depth cellular insights continues to grow in the fields of drug development, personalized medicine, and precision healthcare, the Cellular Health Assays market is poised for continuous growth, offering indispensable solutions for advancing our understanding of cellular biology and improving health-related research and outcomes.
This report aims to provide a comprehensive presentation of the global market for Cellular Health Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cellular Health Assays.
Report Scope
The Cellular Health Assays market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cellular Health Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cellular Health Assays companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Promega Corporation
Abcam
Perkinelmer
Abzena
General Healthcare
Merck
BD Medical
Quidel
Danaher
Corning
Life Technologies
Lonza
Cell Biolabs, Inc.
Bio-Rad Laboratories, Inc.
Segment by Type
Consumables
Instruments
Services
Software
Segment by Application
Pharmaceutical and Biotechnology Companies
Academic and Government Institutions
Contract Research Organizations
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cellular Health Assays companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Cell Health Assays are designed to measure various parameters leading to cell viability, cell death (apoptosis or necrosis), cytotoxicity and cell proliferation.
The global Cellular Health Assays market was valued at US$ 2622.1 million in 2023 and is anticipated to reach US$ 4435.9 million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.
The Cellular Health Assays market is a pivotal and rapidly advancing segment within the life sciences and pharmaceutical industry, providing critical tools for assessing the viability, function, and integrity of cells. Cellular health assays encompass a diverse range of techniques, including cell proliferation assays, cell viability assays, and cytotoxicity assays, which are instrumental in drug development, disease research, and toxicology testing. These assays are highly valued for their ability to offer insights into cellular responses, mechanisms, and drug effects, enabling researchers to make informed decisions in areas like drug discovery, cancer research, and regenerative medicine. The market is characterized by ongoing technological advancements, such as high-throughput screening methods, 3D cell culture systems, and automation, which enhance the efficiency and accuracy of cellular health assessments. Leading providers in the life sciences and biotechnology sector, including Thermo Fisher Scientific, Promega Corporation, and PerkinElmer, focus on delivering advanced assay technologies that cater to the diverse demands of researchers and pharmaceutical companies. As the need for in-depth cellular insights continues to grow in the fields of drug development, personalized medicine, and precision healthcare, the Cellular Health Assays market is poised for continuous growth, offering indispensable solutions for advancing our understanding of cellular biology and improving health-related research and outcomes.
This report aims to provide a comprehensive presentation of the global market for Cellular Health Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cellular Health Assays.
Report Scope
The Cellular Health Assays market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cellular Health Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cellular Health Assays companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Promega Corporation
Abcam
Perkinelmer
Abzena
General Healthcare
Merck
BD Medical
Quidel
Danaher
Corning
Life Technologies
Lonza
Cell Biolabs, Inc.
Bio-Rad Laboratories, Inc.
Segment by Type
Consumables
Instruments
Services
Software
Segment by Application
Pharmaceutical and Biotechnology Companies
Academic and Government Institutions
Contract Research Organizations
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cellular Health Assays companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cellular Health Assays Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Consumables
1.2.3 Instruments
1.2.4 Services
1.2.5 Software
1.3 Market by Application
1.3.1 Global Cellular Health Assays Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Academic and Government Institutions
1.3.4 Contract Research Organizations
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cellular Health Assays Market Perspective (2019-2030)
2.2 Cellular Health Assays Growth Trends by Region
2.2.1 Global Cellular Health Assays Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cellular Health Assays Historic Market Size by Region (2019-2024)
2.2.3 Cellular Health Assays Forecasted Market Size by Region (2025-2030)
2.3 Cellular Health Assays Market Dynamics
2.3.1 Cellular Health Assays Industry Trends
2.3.2 Cellular Health Assays Market Drivers
2.3.3 Cellular Health Assays Market Challenges
2.3.4 Cellular Health Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cellular Health Assays Players by Revenue
3.1.1 Global Top Cellular Health Assays Players by Revenue (2019-2024)
3.1.2 Global Cellular Health Assays Revenue Market Share by Players (2019-2024)
3.2 Global Cellular Health Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cellular Health Assays Revenue
3.4 Global Cellular Health Assays Market Concentration Ratio
3.4.1 Global Cellular Health Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cellular Health Assays Revenue in 2023
3.5 Cellular Health Assays Key Players Head office and Area Served
3.6 Key Players Cellular Health Assays Product Solution and Service
3.7 Date of Enter into Cellular Health Assays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cellular Health Assays Breakdown Data by Type
4.1 Global Cellular Health Assays Historic Market Size by Type (2019-2024)
4.2 Global Cellular Health Assays Forecasted Market Size by Type (2025-2030)
5 Cellular Health Assays Breakdown Data by Application
5.1 Global Cellular Health Assays Historic Market Size by Application (2019-2024)
5.2 Global Cellular Health Assays Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cellular Health Assays Market Size (2019-2030)
6.2 North America Cellular Health Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cellular Health Assays Market Size by Country (2019-2024)
6.4 North America Cellular Health Assays Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cellular Health Assays Market Size (2019-2030)
7.2 Europe Cellular Health Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cellular Health Assays Market Size by Country (2019-2024)
7.4 Europe Cellular Health Assays Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cellular Health Assays Market Size (2019-2030)
8.2 Asia-Pacific Cellular Health Assays Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cellular Health Assays Market Size by Region (2019-2024)
8.4 Asia-Pacific Cellular Health Assays Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cellular Health Assays Market Size (2019-2030)
9.2 Latin America Cellular Health Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cellular Health Assays Market Size by Country (2019-2024)
9.4 Latin America Cellular Health Assays Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cellular Health Assays Market Size (2019-2030)
10.2 Middle East & Africa Cellular Health Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cellular Health Assays Market Size by Country (2019-2024)
10.4 Middle East & Africa Cellular Health Assays Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Cellular Health Assays Introduction
11.1.4 Thermo Fisher Scientific Revenue in Cellular Health Assays Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Promega Corporation
11.2.1 Promega Corporation Company Detail
11.2.2 Promega Corporation Business Overview
11.2.3 Promega Corporation Cellular Health Assays Introduction
11.2.4 Promega Corporation Revenue in Cellular Health Assays Business (2019-2024)
11.2.5 Promega Corporation Recent Development
11.3 Abcam
11.3.1 Abcam Company Detail
11.3.2 Abcam Business Overview
11.3.3 Abcam Cellular Health Assays Introduction
11.3.4 Abcam Revenue in Cellular Health Assays Business (2019-2024)
11.3.5 Abcam Recent Development
11.4 Perkinelmer
11.4.1 Perkinelmer Company Detail
11.4.2 Perkinelmer Business Overview
11.4.3 Perkinelmer Cellular Health Assays Introduction
11.4.4 Perkinelmer Revenue in Cellular Health Assays Business (2019-2024)
11.4.5 Perkinelmer Recent Development
11.5 Abzena
11.5.1 Abzena Company Detail
11.5.2 Abzena Business Overview
11.5.3 Abzena Cellular Health Assays Introduction
11.5.4 Abzena Revenue in Cellular Health Assays Business (2019-2024)
11.5.5 Abzena Recent Development
11.6 General Healthcare
11.6.1 General Healthcare Company Detail
11.6.2 General Healthcare Business Overview
11.6.3 General Healthcare Cellular Health Assays Introduction
11.6.4 General Healthcare Revenue in Cellular Health Assays Business (2019-2024)
11.6.5 General Healthcare Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Cellular Health Assays Introduction
11.7.4 Merck Revenue in Cellular Health Assays Business (2019-2024)
11.7.5 Merck Recent Development
11.8 BD Medical
11.8.1 BD Medical Company Detail
11.8.2 BD Medical Business Overview
11.8.3 BD Medical Cellular Health Assays Introduction
11.8.4 BD Medical Revenue in Cellular Health Assays Business (2019-2024)
11.8.5 BD Medical Recent Development
11.9 Quidel
11.9.1 Quidel Company Detail
11.9.2 Quidel Business Overview
11.9.3 Quidel Cellular Health Assays Introduction
11.9.4 Quidel Revenue in Cellular Health Assays Business (2019-2024)
11.9.5 Quidel Recent Development
11.10 Danaher
11.10.1 Danaher Company Detail
11.10.2 Danaher Business Overview
11.10.3 Danaher Cellular Health Assays Introduction
11.10.4 Danaher Revenue in Cellular Health Assays Business (2019-2024)
11.10.5 Danaher Recent Development
11.11 Corning
11.11.1 Corning Company Detail
11.11.2 Corning Business Overview
11.11.3 Corning Cellular Health Assays Introduction
11.11.4 Corning Revenue in Cellular Health Assays Business (2019-2024)
11.11.5 Corning Recent Development
11.12 Life Technologies
11.12.1 Life Technologies Company Detail
11.12.2 Life Technologies Business Overview
11.12.3 Life Technologies Cellular Health Assays Introduction
11.12.4 Life Technologies Revenue in Cellular Health Assays Business (2019-2024)
11.12.5 Life Technologies Recent Development
11.13 Lonza
11.13.1 Lonza Company Detail
11.13.2 Lonza Business Overview
11.13.3 Lonza Cellular Health Assays Introduction
11.13.4 Lonza Revenue in Cellular Health Assays Business (2019-2024)
11.13.5 Lonza Recent Development
11.14 Cell Biolabs, Inc.
11.14.1 Cell Biolabs, Inc. Company Detail
11.14.2 Cell Biolabs, Inc. Business Overview
11.14.3 Cell Biolabs, Inc. Cellular Health Assays Introduction
11.14.4 Cell Biolabs, Inc. Revenue in Cellular Health Assays Business (2019-2024)
11.14.5 Cell Biolabs, Inc. Recent Development
11.15 Bio-Rad Laboratories, Inc.
11.15.1 Bio-Rad Laboratories, Inc. Company Detail
11.15.2 Bio-Rad Laboratories, Inc. Business Overview
11.15.3 Bio-Rad Laboratories, Inc. Cellular Health Assays Introduction
11.15.4 Bio-Rad Laboratories, Inc. Revenue in Cellular Health Assays Business (2019-2024)
11.15.5 Bio-Rad Laboratories, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
